Codagenix Eyes '23 Nasal RSV Vaccine Readout As GSK, Pfizer Set To Establish Lead

Second Cancer Candidate In Pipeline

Research in progress
Codagenix Has Multiple Vaccine Candidates In The Making • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip